STAT+: Can ultrasound unlock the power of gene therapy? A startup makes big claims
Sonothera is developing a new way to deliver genes into cells that, if borne out, could have a big impact on muscular dystrophy and other diseases.
NASA·USGS·WHO 등 과학·연구·보건 기관의 공식 자료. Public Domain / WHO 라이선스로 본문 직접 표시.
총 423건
Sonothera is developing a new way to deliver genes into cells that, if borne out, could have a big impact on muscular dystrophy and other diseases.
“‘Deprescribing’ elevated into a movement, and a cultural default, is a clinical hazard,” writes Sunny Patel.
MDCalc is launching a quality-rating system for the more than 800 clinical calculators used to assess disease risk, transplant eligibility, and more.
Advocates worry that excluding trans youth in some way from LGBTQ+ counseling services provided through the 988 crisis line could be harmful.
Turmoil at the ADA has taken a fresh turn, with leaders blocking editors at its flagship journal from publishing pieces detailing a controversy at the group’s annual meeting.
This week on "The Readout LOUD" podcast: a new Alzheimer's drug controversy and prediction markets for clinical trials and FDA drug reviews. Listen now.
The Trump administration is testing the use of AI in Medicare to approve some medical services.
Insurance giant UnitedHealth signals the cost of providing workers with health insurance will climb even higher.
The government of Uganda has gone quiet on an outbreak of the deadly Marburg virus that it reported late last month, the WHO acknowledged.
A brain-computer interface helped restore movement and sensation in a 48-year old man with quadriplegia, researchers say.
In this edition of STAT Health Tech: Centers for Medicare and Medicaid Services proposes major changes to RPM, clinical AI payment models.
Kalshi allows bets on clinical trial outcomes, Eli Lilly buys a psychedelic medicine, and more biotech news from The Readout
Eli Lilly is buying the psychedelics-focused biotech AtaiBeckley for $2.8 billion upfront, a move that will expand its neuroscience pipeline.
Trump's pandemic preparedness nominee testifies, the "fang-to-pharmacy" pipeline, and more health news from Morning Rounds
Amylyx Pharmaceuticals will soon read out results from a study evaluating a new treatment for a rare endocrine disorder, a pivotal moment for patients and the company.
“Some of the most powerful medicines we will ever find are already here, carried in the fangs, stingers, and saliva of creatures we’ve been taught to fear,” writes Steve Midway.
“No one built a psychiatric unit to solve hunger,” writes clinical dietician Cole Hanson. But patients come anyway.
CMS wants to build a standardized payment structure for clinical software and AI that factors in their impact on patient outcomes.
When the body’s most important blood vessel tears from the inside, it’s a medical emergency that can be years in the making.
When the body’s most important blood vessel tears from the inside, it’s a medical emergency that can be years in the making.